Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

524 public trials 244 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Recruiting

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

NCT05103683

Conditions
Adnexal Diseases, Advanced Solid Tumor, Endocrine Gland Neoplasms, +19 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • University of Kentucky Medical Center Lexington, Kentucky, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View all 14 locations
View Trial Details
Recruiting

An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).

NCT06634849

Conditions
Advanced Solid Tumor, Neoplasms
Locations
  • Blacktown Hospital Blacktown, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Southern Oncology Clinical Research Unit (SOCRU) Adelaide, South Australia, Australia
  • Austin Health Heidelberg, Victoria, Australia
View Trial Details
Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

NCT05892718

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Hematology-Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • Carolina BioOncology Huntersville, North Carolina, United States
  • Greenville Hospital System University Medical Center (ITOR) Greenville, South Carolina, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Recruiting

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

NCT06484985

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Hunan Cancer Hosptial Changsha, China
  • Fujian Cancer Hospital Fuzhou, China
  • Sun Yat-Sen University Cancer Center Guangzhou, China
View Trial Details
Recruiting

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration

NCT06959615

Conditions
Advanced Solid Tumor, Colonic Diseases, Colorectal Neoplasms, +13 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing Chest Hospital Beijing, Beijing Municipality, China
View all 32 locations
View Trial Details

Related conditions